Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hereditary Cancer Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hereditary Cancer Testingmarket, defines the market attractiveness level of Hereditary Cancer Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hereditary Cancer Testing industry, describes the types of Hereditary Cancer Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hereditary Cancer Testing market and the development prospects and opportunities of Hereditary Cancer Testing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hereditary Cancer Testing market in Chapter 13.
By Player:
Strand Life Sciences
Invitae Corporation
Myriad Genetics
Pathway Genomics
Quest Diagnostics
Biocartis
Myogenes
Laboratory Corporation of America
By Type:
Biopsy
Imaging
Others
By End-User:
Hospital
Clinics
Diagnostic Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hereditary Cancer Testing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hereditary Cancer Testing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hereditary Cancer Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hereditary Cancer Testing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hereditary Cancer Testing Market Analysis and Outlook to 2022
-
7.1 Global Hereditary Cancer Testing Consumption (2017-2022)
-
7.2 United States Hereditary Cancer Testing Consumption (2017-2022)
-
7.3 Europe Hereditary Cancer Testing Consumption (2017-2022)
-
7.4 China Hereditary Cancer Testing Consumption (2017-2022)
-
7.5 Japan Hereditary Cancer Testing Consumption (2017-2022)
-
7.6 India Hereditary Cancer Testing Consumption (2017-2022)
-
7.7 South Korea Hereditary Cancer Testing Consumption (2017-2022)
8 Region and Country-wise Hereditary Cancer Testing Market Analysis and Outlook to 2028
-
8.1 Global Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.2 United States Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.3 Europe Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.4 China Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.5 Japan Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.6 India Hereditary Cancer Testing Consumption Forecast (2022-2028)
-
8.7 South Korea Hereditary Cancer Testing Consumption Forecast (2022-2028)
9 Global Hereditary Cancer Testing Market Outlook by Types and Applications to 2022
-
9.1 Global Hereditary Cancer Testing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopsy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Imaging Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hereditary Cancer Testing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
10 Global Hereditary Cancer Testing Market Outlook by Types and Applications to 2028
-
10.1 Global Hereditary Cancer Testing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hereditary Cancer Testing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Hereditary Cancer Testing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hereditary Cancer Testing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hereditary Cancer Testing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hereditary Cancer Testing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hereditary Cancer Testing Market Competitive Analysis
-
14.1 Strand Life Sciences
-
14.1.1 Strand Life Sciences Company Details
-
14.1.2 Strand Life Sciences Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Strand Life Sciences Hereditary Cancer Testing Product and Service
-
14.2 Invitae Corporation
-
14.2.1 Invitae Corporation Company Details
-
14.2.2 Invitae Corporation Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Invitae Corporation Hereditary Cancer Testing Product and Service
-
14.3 Myriad Genetics
-
14.3.1 Myriad Genetics Company Details
-
14.3.2 Myriad Genetics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Myriad Genetics Hereditary Cancer Testing Product and Service
-
14.4 Pathway Genomics
-
14.4.1 Pathway Genomics Company Details
-
14.4.2 Pathway Genomics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pathway Genomics Hereditary Cancer Testing Product and Service
-
14.5 Quest Diagnostics
-
14.5.1 Quest Diagnostics Company Details
-
14.5.2 Quest Diagnostics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Quest Diagnostics Hereditary Cancer Testing Product and Service
-
14.6 Biocartis
-
14.6.1 Biocartis Company Details
-
14.6.2 Biocartis Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biocartis Hereditary Cancer Testing Product and Service
-
14.7 Myogenes
-
14.7.1 Myogenes Company Details
-
14.7.2 Myogenes Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Myogenes Hereditary Cancer Testing Product and Service
-
14.8 Laboratory Corporation of America
-
14.8.1 Laboratory Corporation of America Company Details
-
14.8.2 Laboratory Corporation of America Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Laboratory Corporation of America Hereditary Cancer Testing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hereditary Cancer Testing
-
Figure Hereditary Cancer Testing Picture
-
Table Global Hereditary Cancer Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Cancer Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Cancer Testing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hereditary Cancer Testing Consumption by Country (2017-2022)
-
Figure United States Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Table Europe Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Figure China Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Figure Japan Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Figure India Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hereditary Cancer Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Hereditary Cancer Testing Consumption Forecast by Country (2022-2028)
-
Figure United States Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hereditary Cancer Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopsy Consumption and Growth Rate (2017-2022)
-
Figure Global Imaging Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hereditary Cancer Testing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hereditary Cancer Testing Export by Region (Top 5 Countries) (2017-2028)
-
Table Strand Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Strand Life Sciences Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strand Life Sciences Hereditary Cancer Testing Product and Service
-
Table Invitae Corporation (Foundation Year, Company Profile and etc.)
-
Table Invitae Corporation Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Invitae Corporation Hereditary Cancer Testing Product and Service
-
Table Myriad Genetics (Foundation Year, Company Profile and etc.)
-
Table Myriad Genetics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics Hereditary Cancer Testing Product and Service
-
Table Pathway Genomics (Foundation Year, Company Profile and etc.)
-
Table Pathway Genomics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pathway Genomics Hereditary Cancer Testing Product and Service
-
Table Quest Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Hereditary Cancer Testing Product and Service
-
Table Biocartis (Foundation Year, Company Profile and etc.)
-
Table Biocartis Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocartis Hereditary Cancer Testing Product and Service
-
Table Myogenes (Foundation Year, Company Profile and etc.)
-
Table Myogenes Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myogenes Hereditary Cancer Testing Product and Service
-
Table Laboratory Corporation of America (Foundation Year, Company Profile and etc.)
-
Table Laboratory Corporation of America Hereditary Cancer Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Hereditary Cancer Testing Product and Service
-
